SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-134506
Filing Date
2021-11-04
Accepted
2021-11-04 17:20:03
Documents
15
Period of Report
2021-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131488d4_8k.htm   iXBRL 8-K 29814
2 EXHIBIT 1.1 tm2131488d4_ex1-1.htm EX-1.1 258198
3 EXHIBIT 5.1 tm2131488d4_ex5-1.htm EX-5.1 10266
7 GRAPHIC tm2131488d4_ex5-1img01.jpg GRAPHIC 2588
  Complete submission text file 0001104659-21-134506.txt   542624

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anip-20211103.xsd EX-101.SCH 3219
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20211103_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20211103_pre.xml EX-101.PRE 22733
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2131488d4_8k_htm.xml XML 3468
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 211381179
SIC: 2834 Pharmaceutical Preparations